Welch Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93.5M | Buy |
371,366
+5,433
| +1% | +$1.17M | 3.19% | 3 |
|
|
2026
Q1 | $79.6M | Sell |
365,933
-1,664
| -0.5% | -$369K | 2.99% | 7 |
|
|
2025
Q4 | $84M | Sell |
367,597
-2,911
| -0.8% | -$663K | 3.24% | 6 |
|
|
2025
Q3 | $85.8M | Buy |
370,508
+3,149
| +0.9% | +$641K | 3.35% | 5 |
|
|
2025
Q2 | $68.2M | Buy |
367,359
+5,347
| +1% | +$994K | 2.85% | 9 |
|
|
2025
Q1 | $74.3M | Sell |
362,012
-2,504
| -0.7% | -$487K | 3.27% | 5 |
|
|
2024
Q4 | $64.2M | Buy |
364,516
+4,317
| +1% | +$794K | 2.89% | 9 |
|
|
2024
Q3 | $71.1M | Buy |
360,199
+560
| +0.2% | +$105K | 3.09% | 5 |
|
|
2024
Q2 | $61.7M | Buy |
359,639
+2,198
| +0.6% | +$364K | 2.96% | 7 |
|
|
2024
Q1 | $65.1M | Sell |
357,441
-11,505
| -3% | -$1.98M | 3.23% | 3 |
|
|
2023
Q4 | $57.2M | Buy |
368,946
+5,463
| +2% | +$796K | 3.08% | 6 |
|
|
2023
Q3 | $54.2M | Buy |
363,483
+201
| +0.1% | +$29.5K | 3.21% | 7 |
|
|
2023
Q2 | $48.9M | Buy |
363,282
+2,981
| +0.8% | +$437K | 2.81% | 13 |
|
|
2023
Q1 | $57.4M | Sell |
360,301
-9,237
| -2% | -$1.41M | 3.34% | 4 |
|
|
2022
Q4 | $59.7M | Sell |
369,538
-4,105
| -1% | -$629K | 3.42% | 4 |
|
|
2022
Q3 | $50.1M | Buy |
373,643
+2,782
| +0.8% | +$399K | 3.26% | 7 |
|
|
2022
Q2 | $56.8M | Sell |
370,861
-7,446
| -2% | -$1.14M | 3.47% | 3 |
|
|
2022
Q1 | $61.3M | Sell |
378,307
-2,901
| -0.8% | -$421K | 3.5% | 5 |
|
|
2021
Q4 | $51.6M | Buy |
381,208
+8,530
| +2% | +$1.01M | 3.02% | 6 |
|
|
2021
Q3 | $40.2M | Buy |
372,678
+4,468
| +1% | +$511K | 2.72% | 9 |
|
|
2021
Q2 | $41.5M | Buy |
368,210
+1,193
| +0.3% | +$134K | 2.83% | 6 |
|
|
2021
Q1 | $39.7M | Sell |
367,017
-6,797
| -2% | -$727K | 2.86% | 10 |
|
|
2020
Q4 | $40.1M | Sell |
373,814
-6,102
| -2% | -$586K | 3.21% | 6 |
|
|
2020
Q3 | $33.3M | Sell |
379,916
-5,227
| -1% | -$492K | 2.91% | 15 |
|
|
2020
Q2 | $37.8M | Sell |
385,143
-4,073
| -1% | -$359K | 3.53% | 4 |
|
|
2020
Q1 | $29.7M | Buy |
389,216
+27,927
| +8% | +$2.38M | 3.16% | 9 |
|
|
2019
Q4 | $32M | Buy |
361,289
+8,786
| +2% | +$729K | 3.15% | 9 |
|
|
2019
Q3 | $26.7M | Buy |
352,503
+33,042
| +10% | +$2.27M | 2.74% | 24 |
|
|
2019
Q2 | $23.2M | Buy |
319,461
+21,654
| +7% | +$1.7M | 2.48% | 28 |
|
|
2019
Q1 | $24M | Buy |
297,807
+11,570
| +4% | +$947K | 2.64% | 28 |
|
|
2018
Q4 | $26.4M | Buy |
286,237
+4,021
| +1% | +$354K | 3.23% | 7 |
|
|
2018
Q3 | $26.7K | Buy |
282,216
+3,225
| +1% | +$306K | 2.78% | 12 |
|
|
2018
Q2 | $25.8M | Sell |
278,991
-5,968
| -2% | -$583K | 3.22% | 8 |
|
|
2018
Q1 | $27M | Buy |
284,959
+41,303
| +17% | +$4.54M | 3.42% | 3 |
|
|
2017
Q4 | $23.6M | Sell |
243,656
-10,575
| -4% | -$997K | 3.66% | 1 |
|
|
2017
Q3 | $22.6M | Sell |
254,231
-6,553
| -3% | -$499K | 3.78% | 1 |
|
|
2017
Q2 | $18.9M | Buy |
260,784
+14,891
| +6% | +$1M | 3.15% | 3 |
|
|
2017
Q1 | $16M | Buy |
245,893
+5,413
| +2% | +$340K | 3.02% | 15 |
|
|
2016
Q4 | $15.1M | Buy |
240,480
+8,394
| +4% | +$512K | 2.94% | 18 |
|
|
2016
Q3 | $14.6M | Buy |
232,086
+2,384
| +1% | +$154K | 2.91% | 15 |
|
|
2016
Q2 | $14.2M | Sell |
229,702
-54,838
| -19% | -$3.34M | 2.9% | 20 |
|
|
2016
Q1 | $16.3M | Buy |
284,540
+12,834
| +5% | +$715K | 2.71% | 25 |
|
|
2015
Q4 | $16.1M | Buy |
271,706
+4,453
| +2% | +$256K | 2.89% | 18 |
|
|
2015
Q3 | $14.5M | Buy |
267,253
+4,293
| +2% | +$279K | 2.81% | 21 |
|
|
2015
Q2 | $17.7M | Sell |
262,960
-908
| -0.3% | -$59.3K | 3.34% | 3 |
|
|
2015
Q1 | $15.4K | Buy |
263,868
+4,439
| +2% | +$268K | 2.84% | 16 |
|
|
2014
Q4 | $17M | Sell |
259,429
-5,959
| -2% | -$376K | 3.27% | 5 |
|
|
2014
Q3 | $15.3M | Buy |
265,388
+1,275
| +0.5% | +$70.8K | 3.17% | 6 |
|
|
2014
Q2 | $14.9M | Buy |
264,113
+1,435
| +0.5% | +$75.3K | 3.09% | 4 |
|
|
2014
Q1 | $13.5M | Sell |
262,678
-12,667
| -5% | -$640K | 3.06% | 7 |
|
|
2013
Q4 | $14.5M | Sell |
275,345
-2,110
| -0.8% | -$104K | 3.3% | 3 |
|
|
2013
Q3 | $12.4M | Buy |
277,455
+2,623
| +1% | +$116K | 3.05% | 5 |
|
|
2013
Q2 | $11.4M | Buy |
+274,832
| New | +$12M | 2.95% | 9 |
|
Other funds holding ABBV
ECSS
ATO
Welch Group's ABBV Position: Q2 2026 in Review
Welch Group increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $1.17M and bringing the position to 371,366 shares worth $93.5M. The position accounts for 3.19% of the portfolio, ranked #3.
Welch Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,884 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Welch Group held 371,366 shares of AbbVie worth $93.5M as of Q2 2026.
- Welch Group bought 5,433 AbbVie shares in Q2 2026, an estimated $1.17M.
- AbbVie made up 3.19% of Welch Group's portfolio in Q2 2026, its #3 holding.
- Welch Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,884 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.